Agilent Technologies (NYSE:A) Stock

Agilent Technologies

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Each week, Benzinga&#8217;s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45750724/exclusive-mays-20-most-searched-tickers-on-benzinga-pro-where-do-apple-palantir-coreweave-nvidia-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: May's 20 Most-Searched Tickers On Benzinga Pro — Where Do Apple, Palantir, CoreWeave, Nvidia Rank?</a>
Here's a look at the Benzinga Stock Whisper Index for the week ending June 27:
Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>): The logistics real estate company saw increased interest from readers during the week. The company was recently named to the <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/46144750/44-public-companies-make-times-most-influential-list-coinbase-ufc-nintendo-netflix-and-more-stocks-investors-can-buy">TIME 100 Most Influential Companies list</a> in the "Leaders" category. Investors may be gearing up for second quarter financial results, which are set for July 16. The company has beaten funds from operation estimates from analysts in four straight quarters, while revenue has missed analyst estimates in six straight quarters. Prologis could be fitting several themes for investors with a dividend payment and operating in the growing logistics REIT market. The stock was nearly flat on the week, as seen on the <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0627">Benzinga Pro chart </a>below and shares are up only 1.3% year-to-date in 2025.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0627"><img loading="lazy" decoding="async" width="997" height="498" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172832/Screenshot-471.png" alt="" class="wp-image-965471" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172832/Screenshot-471.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172832/Screenshot-471-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172832/Screenshot-471-768x384.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Global-E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>): The ecommerce solutions company saw strong interest from readers during the week with the stock price up 6%. The company<a href="https://www.benzinga.com/25/05/45410991/global-e-q1-sales-up-30-gmv-soars-34-extends-strategic-partnership-with-shopify"> reported first-quarter financial results</a> in May with sales beating analyst estimates. The company saw 30% year-over-year sales growth and gross merchandise value also rose 34% year-over-year in the quarter. Global-E Online also reported growth in its Adjusted EBITDA with the operating loss narrowing. The company reiterated its full year guidance after the quarter. Along with financial results, Global-E Online also announced a new three-year strategic partnership with Shopify, extending an existing long-term partnership for first-party and third-party solutions.
"We had another quarter of strong results,&nbsp;demonstrating our ability to grow fast even within macroeconomic turbulent times with Q1 results coming in at or above the midpoints across our guidance," founder and CEO&nbsp;Amir Schlachet&nbsp;said. &nbsp;
Schlachet said the company's pipeline is very active and the company is seeing increased interest in its services.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0627"><img loading="lazy" decoding="async" width="993" height="499" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172847/Screenshot-472.png" alt="" class="wp-image-965472" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172847/Screenshot-472.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172847/Screenshot-472-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172847/Screenshot-472-768x386.png 768w" sizes="(max-width: 993px) 100vw, 993px" /></a></figure>
Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>): The life sciences and diagnostics company saw increased interest from investors during the week, which comes after the company reported quarterly financial results <a href="https://www.benzinga.com/general/health-care/25/05/45669099/agilent-braces-for-potential-us-eu-tariff-hike-maintains-annual-outlook">last month</a>. Agilent reported 6% year-over-year sales growth, which beat analyst estimates. The company beat revenue estimates from analysts for a fourth straight quarter and ninth time out of the last 10 quarters. The company's earnings per share also beat analyst estimates, which kept a streak of more than 10 straight quarters beating estimates in place. Agilent reaffirmed earnings per share guidance for the full year and raised its full-year sales guidance, saying that it will be able to mitigate most of the impacts of tariffs.
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0627"><img loading="lazy" decoding="async" width="995" height="499" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172902/Screenshot-473.png" alt="" class="wp-image-965473" style="width:920px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172902/Screenshot-473.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172902/Screenshot-473-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172902/Screenshot-473-768x385.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>): Investors showed increased interest in the metals company ahead of its July 16 second-quarter financial results. Analyss expect the company to report earnings per share of 57 cents and revenue of $2.96 billion. The company has beaten analyst estimates for earnings per share in four straight quarters and seven of the last 10 quarters overall. Revenue has been more mixed with a miss in the last quarter and five beats and five misses over the last 10 quarters. Investors are likely looking to hear more on the impact of tariffs for the company. Alcoa reported $20 million in additional costs in <a href="https://www.benzinga.com/news/earnings/25/04/44853254/alcoa-shares-gain-after-mixed-q1-results-eps-beat-revenues-miss">the first quarter</a> due to the impact of tariffs on Canadian aluminum imports. The forecast for the second quarter impact from tariffs <a href="https://www.benzinga.com/news/earnings/25/04/44858454/alcoa-warns-tariffs-could-cost-425-million-annually-this-is-the-most-material-impact-says-ceo">was $90 million.</a>
&#8220;This is the most material impact to Alcoa, as approximately 70% of our aluminum produced in Canada is destined for U.S. customers,&#8221; Alcoa CEO William Oplinger said.
He estimated the annual cost of the 25% tariff could reach as high as $425 million.
Investors will likely want to hear that these numbers have not gone up and that higher metals prices and demand could help offset some of the increased costs.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0627"><img loading="lazy" decoding="async" width="995" height="504" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172921/Screenshot-474.png" alt="" class="wp-image-965474" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172921/Screenshot-474.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172921/Screenshot-474-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172921/Screenshot-474-768x389.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Comfort Systems USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>): The HVAC and electrical company saw increased interest from investors with shares at all-time highs. While most investors may not be familiar with the company, Comfort Systems has shown consistent growth and has a history of beating analyst estimates. Second quarter financial results are expected in June. Analysts expect the company to report earnings per share of $4.78, up from $3.74 in last year's second quarter. The company has beaten analyst estimates for earnings per share in more than 10 straight quarters. Analysts expect the company to report quarterly revenue of $1.97 billion, up from $1.54 billion in last year's second quarter. The company has beaten analyst estimates in two straight quarters and nine of the last 10 quarters overall. Analysts have <a href="https://www.benzinga.com/quote/FIX/analyst-ratings">raised price targets</a> on the stock in recent months and the new quarterly results could see more analyst action.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0627"><img loading="lazy" decoding="async" width="999" height="506" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172936/Screenshot-475.png" alt="" class="wp-image-965476" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172936/Screenshot-475.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172936/Screenshot-475-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27172936/Screenshot-475-768x389.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Stay tuned for next week&#8217;s report, and follow Benzinga Pro for all the latest headlines and <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0627" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45710022/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-67" target="_blank" rel="noreferrer noopener">May 30</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45827517/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-68" target="_blank" rel="noreferrer noopener">June 6</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45938888/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-69" target="_blank" rel="noreferrer noopener">June 13</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/46043300/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-70">June 20</a></li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45932660/exclusive-sp-500-new-all-time-highs-again-2025" target="_blank" rel="noreferrer noopener">EXCLUSIVE: S&amp;P 500 To Hit New All-Time Highs Again In 2025? Majority Say Yes, 27% Predict This Range</a></li>
</ul>

Exclusives

Trading Ideas

GLBE

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Agilent Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) short percent of float has fallen 5.17% since its last report. The company recently reported that it has 4.14 million shares sold short, which is 1.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.56 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Agilent Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750795220_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Agilent Technologies has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Agilent Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Agilent Technologies's peer group average for short interest as a percentage of float is 7.92%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Agilent Technologies's Recent Short Interest

Barclays analyst Luke Sergott maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Equal-Weight and raises the price target from $115 to $125.

News

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Agilent Technologies, Raises Price Target to $125

UBS analyst Elizabeth Garcia maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Neutral and lowers the price target from $150 to $130.

UBS Maintains Neutral on Agilent Technologies, Lowers Price Target to $130

Wall Street hovered slightly higher by midday Thursday, giving up a chunk of strong overnight gains in futures markets that were triggered by a federal court ruling suspending a large portion <a href="https://www.benzinga.com/government/regulations/25/05/45672421/tariffs-blocked-by-court-but-goldman-sachs-says-trump-could-reimpose-them-within-days">of President Donald Trump&#8217;s tariffs.</a>
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) led the market after reporting a better-than-feared quarter. The artificial intelligence leader showed resilience in the face of export restrictions. Shares rose 4.3%, ranking as the second-best performer on the S&amp;P 500 and climbing to their highest level in more than three months.
By midday: 
<ul class="wp-block-list">
<li>The S&amp;P 500 was up 0.3% at 5,900.</li>
<li>The Nasdaq 100 gained 0.5%.</li>
<li>The Dow Jones Industrial Average traded flat.</li>
</ul>
<h3 class="wp-block-heading">Fresh Economic Data Adds To Mixed Tone</h3>
First-quarter U.S. gross domestic product shrank 0.2%, slightly improving from the initial 0.3% estimate. Still, it marked a sharp slowdown compared to the 2.4% growth in the last quarter of 2024, reflecting slower consumer spending and higher imports ahead of the tariffs impact.
More concerning was the labor market. Initial jobless claims for the week ending May 24 jumped to 240,000, exceeding expectations and reaching their highest level in nearly four months. Continuing claims also rose to levels last seen in November 2021, indicating potential softening in employment trends.
The U.S. dollar pulled back, nearly wiping out gains from the prior two sessions as traders reassessed the outlook for interest rates. Meanwhile, Treasury yields dropped, with the 30-year note falling to 4.92% and the 10-year yield easing to 4.42%.
Federal Reserve Chair Jerome Powell met with Trump at the White House, the Fed confirmed.
The meeting focused on recent economic developments, including inflation, employment and growth. Powell reiterated that the Fed&#8217;s policy path would remain dependent on incoming data but refrained from commenting on future rate decisions.
Gold climbed 1.1% to $3,320 per ounce, buoyed by lower yields and dollar weakness. Meanwhile, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell below $107,000, giving up recent gains as risk appetite moderated in crypto markets.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>1-day %Chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,414.87</td>
<td>0.5%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,906.48</td>
<td>0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,069.76</td>
<td>0.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,091.08</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:55 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.3% up to $589.37.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.1% to $420.98.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 0.4% to $520.87.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) flattened at $205.62.</li>
<li>The&nbsp;Technology&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 0.4%; the&nbsp;Communication Services&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
<ul class="wp-block-list">
<li>Shares of E.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) surged 26% Thursday afternoon, following the company&#8217;s announcement of its acquisition of lifestyle cosmetics brand Rhode.</li>
<li>Sentinel One Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) tumbled 11% after BofA Securities downgraded&nbsp;the stock from &#8216;Buy&#8217; to &#8216;Neutral&#8217; citing &#8220;weak trends and lackluster guidance&#8221; while lowering its price target from $24 to $21. </li>
</ul>
Stocks reacting to earnings included: 
<ul class="wp-block-list">
<li>Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) down 5.42%</li>
<li>Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) up 0.20%</li>
<li>Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) up 18.45%</li>
<li>Agilent Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) up 3.17%</li>
<li>HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) down 8.23%</li>
<li>Hormel Foods Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRL#NYSE">HRL</a>) down 0.35%</li>
<li>Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) down 3.22%</li>
<li>Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) down 7.90%</li>
<li>Nordson Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) up 5.65%</li>
<li>Hamilton Lane Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) down 11.21%</li>
<li>Roivant Sciences Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROIV#NASDAQ">ROIV</a>) up 5.50%</li>
<li>Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) down 6.24%</li>
<li>Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) up 0.10%</li>
</ul>
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45675006/nvidia-stock-has-significant-upside-as-ai-godfather-jensen-huang-delivers-another-robust-quarter">Nvidia Stock Has &#8216;Significant Upside&#8217; As AI &#8216;Godfather&#8217; Jensen Huang Delivers Another &#8216;Robust Quarter&#8217; </a></li>
</ul>
Image: Shutterstock

Equities

Government

Large Cap

Macro Economic Events

Regulations

Bonds

Broad U.S. Equity ETFs

Treasuries

Economics

Federal Reserve

ETFs

$BTC

BBWI

BURL

SPDR Dow Jones Industrial Average ETF Trust

HLNE

NDSN

NVDA

ROIV

SNPS

VEEV

Select Sector SPDR-Consumer Discretionary

Stocks Edge Higher After Court Stifles Trump Tariffs, Nvidia Rallies To 3-Month Highs, Bitcoin Dips Below $107K: What's Driving Markets Thursday?

JP Morgan analyst Tycho Peterson maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Overweight and lowers the price target from $160 to $155.

JP Morgan Maintains Overweight on Agilent Technologies, Lowers Price Target to $155

U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 100 points on Thursday.
Shares of Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) rose sharply during Thursday's session <a href="https://in.benzinga.com/trading-ideas/movers/25/05/45668750/why-veeva-systems-stock-is-gaining-today">following strong quarterly results.</a>
The company reported adjusted earnings per share of $1.97, beating the analyst consensus estimate of $1.77. Quarterly sales of $759 million (+17% year over year) outpaced the Street view of $731.91 million.
For the full fiscal year ending January 31, 2026, the company projects total revenue between $3.09 billion and $3.10 billion versus the Street view of $3.09 billion (prior view: $3.040 billion to $3.055 billion), non-GAAP operating income of approximately $1.36 billion, and adjusted diluted EPS of around $7.63 versus the Street view of $7.56 (Prior view: $7.32).
Veeva Systems shares jumped 19.9% to $281.10 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>ORIC Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIC#NASDAQ">ORIC</a>) shares jumped 32% to $7.88 after the company announced preliminary efficacy and safety data from its ongoing Phase 1b trial of ORIC-944. Additionally, the company announced a $125 million private placement, which was priced at an 18% premium to its 10-day trailing volume-weighted average price.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) gained 28.2% to $25.01.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) jumped 27% to $114.92 after the company reported better-than-expected quarterly results and announced it will acquire Rhode.</li>
<li>C3.ai, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) gained 26.7% to $29.22 after the company reported better-than-expected fourth-quarter financial results and announced a renewal and expansion of its joint venture with Baker Hughes for accelerated AI-driven transformations in the energy and industrial sectors.</li>
<li>Claritev Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTEV#NYSE">CTEV</a>) gained 23.6% to $32.96.</li>
<li>SS Innovations International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) rose 19.5% to $6.07.</li>
<li>BRP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) gained 12.1% to $40.28 after the company reported better-than-expected quarterly financial results. Additionally, the company announced that its president, CEO, and chair of the board will retire by the end of the fiscal year.</li>
<li>Nordson Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) rose 9.3% to $213.89 following upbeat quarterly results.</li>
<li>CoreWeave, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) gained 6% to $122.78.</li>
<li>Agilent Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) rose 4.3% to $115.69 following strong quarterly results.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45641430/jim-cramer-says-this-quantum-computing-stock-is-so-high-and-too-speculative">Jim Cramer Says This Quantum Computing Stock Is &#8216;So High&#8217; And &#8216;Too Speculative&#8217;</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Movers

CRWV

CTEV

DOOO

LZMH

ORIC

SSII

Veeva Systems, e.l.f. Beauty, C3.ai, BRP And Other Big Stocks Moving Higher On Thursday

Agilent Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45656371/agilent-reports-second-quarter-fiscal-year-2025-financial-results" rel="noreferrer noopener">second-quarter 2025</a> sales of $1.67 billion on Wednesday, almost in line with the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $1.63 billion</a>, representing growth of 6% reported and up 5.3% core year-over-year.
The Life Sciences and Diagnostics Markets Group (LDG) reported second-quarter revenue of $654 million, an increase of 8% reported and 3% core&nbsp;year-over-year. LDG&#8217;s operating margin for the quarter was 19.7%.
The Agilent CrossLab Group (ACG) reported second-quarter revenue of $713 million, an increase of 7% reported and 9% core year-over-year. ACG&#8217;s operating margin for the quarter was 32.4%.
The Applied Markets Group (AMG) reported second-quarter revenue of $301 million, a decrease of 1% reported and flat core year-over-year. AMG&#8217;s operating margin for the quarter was 19.5%.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/05/45655674/rocket-pharmas-gene-therapy-future-clouded-by-regulatory-uncertainty" rel="noreferrer noopener">Rocket Pharma&#8217;s Gene Therapy Future Clouded By Regulatory Uncertainty</a>
The <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">analytical and clinical laboratory</a> technologies provider reported adjusted earnings of $1.31 per share, up from $1.22 a year ago, beating the consensus of $1.26.
&#8220;The Agilent team delivered strong second-quarter results in a highly dynamic market environment,&#8221; said Agilent President and CEO Padraig McDonnell. &#8220;That is in large part due to our Ignite Transformation, which is driving our financial success as it&#8217;s become our core enterprise delivery engine and operating model. Ignite represents a decisive shift to fuel accelerated profitable growth and operational excellence at Agilent.&#8221;
The company&#8217;s&nbsp;operating margin <a target="_blank" href="https://in.investing.com/news/transcripts/earnings-call-transcript-agilent-technologies-q2-2025-beats-forecasts-stock-rises-93CH-4852010" rel="noreferrer noopener">was</a> 25.1% as it absorbed some incremental tariff costs.
In the earnings conference call, McDonnell said, &#8220;Through our tariff task force enabled by our Ignite operating model, we feel that we are able to mitigate most of the impact in 2025 and fully mitigate in 2026 even when considering recent developments on the U.S.-EU tariffs.&#8221;
Agilent reaffirmed fiscal 2025 adjusted earnings of $5.54-$5.61 per share compared to the consensus of $5.55.
The company raised sales guidance from $6.68 billion-$6.76 billion to $6.73 billion-$6.81 billion compared to the consensus of $6.73 billion.
The full-year revenue outlook represents growth of 3.4%-4.6% reported while maintaining core growth of 2.5%-3.5%
Based on the current tariff rates, Agilent estimates that the gross incremental tariff exposure in the second half will be $50 million. This is on top of the roughly $10 million already absorbed in the first half.
The company anticipates potential additional tariff impacts if U.S.-EU tariffs increase, which could add $40 million in gross exposure in the second half of 2025.
The outlook for third-quarter revenue is expected to be $1.65 billion-$1.68 billion versus a consensus of $1.65 billion, representing a growth of 4.2% to 6.1% reported and up 1.7% to 3.6% core.
Agilent sees Q3 adjusted earnings of $1.35-$1.37 versus a consensus of $1.39.
Price Action: A stock is trading higher by 5.52% to $117 premarket at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/health-care/25/05/45634160/elon-musks-neuralink-hits-9-billion-valuation-with-new-funding" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s Neuralink Hits $9 Billion Valuation With New Funding</a></li>
</ul>
Image via Shutterstock

Earnings

Guidance

Health Care

General

Agilent Braces For Potential US-EU Tariff Hike, Maintains Annual Outlook

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) affirms FY2025 Adj EPS guidance from $5.54-$5.61 to $5.54-$5.61 vs $5.55 analyst estimate. Raises FY2025 sales outlook from $6.68 billion-$6.76 billion to $6.73 billion-$6.81 billion vs $6.73 billion estimate.

Agilent Technologies Affirms FY2025 Adj EPS Guidance of $5.54-$5.61 vs $5.55 Est; Raises FY2025 Sales Guidance from $6.68B-$6.76B to $6.73B-$6.81B vs $6.73B Est

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) is looking for Q3 Adj EPS of $1.35-$1.37 vs $1.39 analyst estimate. sees sales of $1.645 billion-$1.675 billion vs $1.65 billion analyst estimate.

Agilent Technologies Sees Q3 Adj EPS $1.35-$1.37 vs $1.39 Est; Sees Sales $1.645B-$1.675B vs $1.65B Est

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.26 by 3.97 percent. This is a 7.38 percent increase over earnings of $1.22 per share from the same period last year. The company reported quarterly sales of $1.67 billion which beat the analyst consensus estimate of $1.63 billion by 2.54 percent. This is a 6.04 percent increase over sales of $1.57 billion the same period last year.

Earnings Beats

Agilent Technologies Q2 Adj. EPS $1.31 Beats $1.26 Estimate, Sales $1.67B Beat $1.63B Estimate

After a sharp Tuesday rally fueled by optimism over improved U.S.-EU trade ties, Wall Street stalled midweek as rising Treasury yields reasserted pressure ahead of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)&#8217;s earnings report and the release of<a href="https://www.benzinga.com/topic/federal-reserve"> key Federal Reserve minutes.</a>
Major U.S. stock indexes paused on Wednesday, digesting recent gains as yields on longer-term Treasury bonds resumed their climb. The S&amp;P 500 slipped 0.2% to 5,900 points by midday in New York, while the tech-heavy Nasdaq 100 held flat. Small-cap stocks underperformed sharply, with the Russell 2000 down 0.8%.
Sector performance was broadly negative, with 9 of the 11 S&amp;P 500 sectors trading lower. Technology and communication services were the only sectors managing to avoid losses. 
All eyes are on Nvidia, which is set to report earnings after Wednesday's closing bell. Wall Street expects earnings per share of 88 cents and revenue of $43.2 billion, according to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a> estimates.
Beyond the headline figures, investors will be closely watching two key aspects: the impact of the U.S. export ban on the H20 chips destined for China and the forward guidance. CEO Jensen Huang already said the company could face a $5 billion annual earnings hit due to export restrictions, making this quarter&#8217;s outlook pivotal for market sentiment.
The Federal Reserve's minutes from its May meeting will also be released. The Federal Open Market Committee left rates unchanged in the 4.25%-4.50% range. Chair Jerome Powell signaled little urgency to cut rates, citing inflation risks partly tied to newly proposed trade tariffs.
Markets will parse the minutes for hints on the Fed's timeline for easing monetary policy, particularly as inflation data remains stubbornly elevated.
After a brief relief, bond markets came under renewed pressure. The yield on the 30-year Treasury note climbed 5 basis points to 5%, while the 10-year yield rose to 4.5%. Investors remain concerned about the trajectory of U.S. fiscal policy, with swelling budget deficits raising doubts about long-term debt sustainability.
The U.S. dollar rallied for a second straight session, decoupling from other U.S. assets. Meanwhile, gold slipped 0.2%, dipping below $3,300 per ounce. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 2%, trading near $107,000 as speculative appetite in cryptocurrencies waned.
<h3 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,427.45</td>
<td>0.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,908.48</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,230.96</td>
<td>-0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,074.61</td>
<td>-0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:10 p.m. ET</figcaption></figure>
According to&nbsp;Benzinga Pro&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.2% down to $589.76.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.3% to $422.71.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;held steady at $521.25.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.8% to $206.15.</li>
<li>The&nbsp;Communication Select&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) outperformed, up 0.2%; the&nbsp;Utilities&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) lagged, down 1.3%.</li>
</ul>
<h3 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h3>
<ul class="wp-block-list">
<li>Vail Resorts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) rallied over 12% – on pace for the strongest one-day rally since March 2020 – after the company announced the reappointment of Rob Katz as CEO. </li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) fell almost 10% after announcing the purchase of 4,710 Bitcoin.</li>
</ul>
Stocks reacting to earnings reports include: 
<ul class="wp-block-list">
<li>HEICO Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>) up 6.67%</li>
<li>Okta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) down 14.62%</li>
<li>DICK&#8217;S Sporting Goods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) up 1.89%</li>
<li>Abercrombie &amp; Fitch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) up 18.83%</li>
<li>Macy&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) up 1.46%</li>
<li>Capri Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) up 3.45%</li>
</ul>
Stocks slated to report earnings after the close include Nvidia Corp, Agilent Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>), Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>), Salesforce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>), Nordson Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>), e.l.f. Beauty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>), nCino Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>), C3.ai Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>), Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>), Pure Storage Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>), and SentinelOne Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>).
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45645056/gold-etf-bleeds-money-at-fastest-pace-in-3-years-is-the-safe-haven-trade-over">Gold ETF Bleeds Money At Fastest Pace In 3 Years — Is The Safe-Haven Trade Over?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Commodities

Global

Econ #s

Tech

CPRI

NCNO

OKTA

PSTG

Wall Street Stalls As Treasury Yields Climb Again Ahead Of Nvidia Earnings, Fed Minutes: What's Driving Markets Wednesday?

<h3>Companies Reporting Before The Bell</h3>
• Eagle Point Credit Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECC#NYSE">ECC</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $52.27 million. 
• Eagle Point Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIC#NYSE">EIC</a>) is expected to report quarterly earnings at $0.45 per share on revenue of $14.25 million. 
• Monro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNRO#NASDAQ">MNRO</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $289.50 million. 
• Sociedad Quimica Y Minera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQM#NYSE">SQM</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $1.02 billion. 
• REX American Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REX#NYSE">REX</a>) is expected to report quarterly earnings at $0.34 per share on revenue of $161.27 million. 
• Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) is likely to report quarterly earnings at $1.33 per share on revenue of $1.06 billion. 
• Reservoir Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSVR#NASDAQ">RSVR</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $40.94 million. 
• CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $9.76 million. 
• Macy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) is likely to report quarterly earnings at $0.15 per share on revenue of $4.43 billion. 
• Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) is projected to report quarterly loss at $0.16 per share on revenue of $982.81 million. 
• VNET Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>) is expected to report quarterly loss at $0.01 per share on revenue of $309.74 million. 
• Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) is estimated to report quarterly earnings at $4.32 per share on revenue of $3.60 billion. 
• Kingsoft Cloud Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) is likely to report earnings for its first quarter. 
• Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) is projected to report quarterly earnings at $2.40 per share on revenue of $3.31 billion. 
• Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) is expected to report quarterly earnings at $1.84 per share on revenue of $6.39 billion. 
• Icecure Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCM#NASDAQ">ICCM</a>) is expected to report quarterly loss at $0.08 per share on revenue of $750 thousand. 
• Amber International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBR#NASDAQ">AMBR</a>) is expected to report earnings for its first quarter. 
• Sono-Tek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOTK#NASDAQ">SOTK</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $5.12 million. 
• OneConnect Financial Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OCFT#NYSE">OCFT</a>) is estimated to report earnings for its first quarter. 
• Columbus McKinnon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCO#NASDAQ">CMCO</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $250.05 million. 
• Photronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAB#NASDAQ">PLAB</a>) is expected to report quarterly earnings at $0.48 per share on revenue of $212.00 million. 
• Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) is likely to report quarterly earnings at $0.70 per share on revenue of $88.47 million. 
<h3>Companies Reporting After The Bell</h3>
• SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) is estimated to report quarterly loss at $0.24 per share on revenue of $228.40 million. 
• e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) is expected to report quarterly earnings at $0.72 per share on revenue of $326.67 million. 
• Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) is estimated to report quarterly earnings at $0.16 per share on revenue of $140.13 million. 
• C3.ai (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) is likely to report quarterly loss at $0.20 per share on revenue of $107.70 million. 
• ATS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATS#NYSE">ATS</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $689.21 million. 
• Nordson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) is likely to report quarterly earnings at $2.36 per share on revenue of $671.91 million. 
• NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is expected to report quarterly earnings at $0.75 per share on revenue of $43.25 billion. 
• HP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) is estimated to report quarterly earnings at $0.80 per share on revenue of $13.12 billion. 
• U-Haul Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHAL#NYSE">UHAL</a>) is likely to report quarterly loss at $0.26 per share on revenue of $1.16 billion. 
• Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) is likely to report quarterly earnings at $1.74 per share on revenue of $728.33 million. 
• Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) is estimated to report quarterly earnings at $3.40 per share on revenue of $1.60 billion. 
• Pure Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) is likely to report quarterly earnings at $0.25 per share on revenue of $770.35 million. 
• Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) is estimated to report quarterly earnings at $1.26 per share on revenue of $1.63 billion. 
• Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $626.75 million. 
• Noah Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) is projected to report earnings for its first quarter. 
• Ooma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OOMA#NYSE">OOMA</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $64.82 million. 
• Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) is projected to report quarterly earnings at $2.55 per share on revenue of $9.75 billion. 
• Phreesia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHR#NYSE">PHR</a>) is projected to report quarterly earnings at $0.16 per share on revenue of $114.98 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMBR

CLGN

CMCO

ICCM

ITRN

MNRO

NOAH

NTNX

OCFT

OOMA

PLAB

RSVR

SOTK

UHAL

VNET

Earnings Scheduled For May 28, 2025

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) will release its quarterly earnings report on Wednesday, 2025-05-28. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Agilent Technologies to report an earnings per share (EPS) of $1.27.
Investors in Agilent Technologies are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat EPS by $0.04, which was followed by a 5.5% drop in the share price the next day.
Here's a look at Agilent Technologies's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.27</td>
<td>1.40</td>
<td>1.26</td>
<td>1.19</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.31</td>
<td>1.46</td>
<td>1.32</td>
<td>1.22</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>-0.0%</td>
<td>0.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748354468_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Agilent Technologies were trading at $108.53 as of May 26. Over the last 52-week period, shares are down 23.67%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analysts' Perspectives on Agilent Technologies</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Agilent Technologies.
With 5 analyst ratings, Agilent Technologies has a consensus rating of Outperform. The average one-year price target is $133.0, indicating a potential 22.55% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of IQVIA Hldgs, Waters and West Pharmaceutical Servs, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for IQVIA Hldgs, with an average 1-year price target of $184.4, suggesting a potential 69.91% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Waters, with an average 1-year price target of $385.14, suggesting a potential 254.87% upside.</li>
<li>Analysts currently favor an Outperform trajectory for West Pharmaceutical Servs, with an average 1-year price target of $275.0, suggesting a potential 153.39% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
In the peer analysis summary, key metrics for IQVIA Hldgs, Waters and West Pharmaceutical Servs are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Agilent Technologies</td>
<td>Outperform</td>
<td>1.39%</td>
<td>$899M</td>
<td>5.33%</td>
</tr>
<tr>
<td>IQVIA Hldgs</td>
<td>Neutral</td>
<td>2.46%</td>
<td>$1.30B</td>
<td>4.13%</td>
</tr>
<tr>
<td>Waters</td>
<td>Outperform</td>
<td>3.90%</td>
<td>$384.96M</td>
<td>6.40%</td>
</tr>
<tr>
<td>West Pharmaceutical Servs</td>
<td>Outperform</td>
<td>0.37%</td>
<td>$231.90M</td>
<td>3.35%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Agilent Technologies ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has a lower Return on Equity compared to one of its peers.
<h3>Delving into Agilent Technologies's Background</h3>
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
<h3>Understanding the Numbers: Agilent Technologies's Finances</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Agilent Technologies displayed positive results in 3 months. As of 31 January, 2025, the company achieved a solid revenue growth rate of approximately 1.39%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Agilent Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 18.92% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Agilent Technologies's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.33% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Agilent Technologies's ROA excels beyond industry benchmarks, reaching 2.68%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.56, Agilent Technologies adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/A/earnings">To track all earnings releases for Agilent Technologies visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Agilent Technologies

Judy Brown, Board Member at Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>), reported an insider buy on May 23, according to a new SEC filing. 
What Happened: Brown made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001090872/000112760225015390//Archives/edgar/data/1090872/000112760225015390/0001127602-25-015390-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $182,642.
In the Friday's morning session, Agilent Technologies's shares are currently trading at $107.48, experiencing a down of 2.01%.
<h3>Discovering Agilent Technologies: A Closer Look</h3>
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
<h3>Breaking Down Agilent Technologies's Financial Performance</h3>
Revenue Growth: Agilent Technologies's revenue growth over a period of 3 months has been noteworthy. As of 31 January, 2025, the company achieved a revenue growth rate of approximately 1.39%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: With a high gross margin of 53.48%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): Agilent Technologies's EPS is below the industry average. The company faced challenges with a current EPS of 1.12. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.56.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 25.16 is lower than the industry average, implying a discounted valuation for Agilent Technologies's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 4.86, Agilent Technologies's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 17.89 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Cracking Transaction Codes</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001090872">Check Out The Full List Of Agilent Technologies's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Judy Brown Of Agilent Technologies Shows Optimism, Buys $182K In Stock

Pascal Soriot, Director at Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>), reported an insider buy on May 23, according to a new SEC filing. 
What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001090872/000112760225015392//Archives/edgar/data/1090872/000112760225015392/0001127602-25-015392-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $182,642.
As of Friday morning, Agilent Technologies shares are down by 2.01%, currently priced at $107.48.
<h3>Get to Know Agilent Technologies Better</h3>
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
<h3>Breaking Down Agilent Technologies's Financial Performance</h3>
Revenue Growth: Over the 3 months period, Agilent Technologies showcased positive performance, achieving a revenue growth rate of 1.39% as of 31 January, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 53.48%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Agilent Technologies's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 1.12.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.56.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 25.16 is lower than the industry average, implying a discounted valuation for Agilent Technologies's stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 4.86 is above industry norms, reflecting an elevated valuation for Agilent Technologies's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 17.89, Agilent Technologies could be considered undervalued.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Relevance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Cracking Transaction Codes</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001090872">Check Out The Full List Of Agilent Technologies's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Positive Signal: Pascal Soriot Shows Faith, Buying $182K In Agilent Technologies Stock

During the last three months, 5 analysts shared their evaluations of Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Agilent Technologies, revealing an average target of $133.0, a high estimate of $159.00, and a low estimate of $115.00. This current average has decreased by 11.1% from the previous average price target of $149.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1747944051_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Agilent Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Catherine Schulte</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$116.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Catherine Schulte</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$159.00</td>
<td>$161.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Agilent Technologies. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Agilent Technologies compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Agilent Technologies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Agilent Technologies's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/A/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Agilent Technologies analyst ratings.</a>
<h2>All You Need to Know About Agilent Technologies</h2>
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
<h3>A Deep Dive into Agilent Technologies's Financials</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Agilent Technologies's revenue growth over a period of 3M has been noteworthy. As of 31 January, 2025, the company achieved a revenue growth rate of approximately 1.39%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 18.92%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Agilent Technologies's ROE excels beyond industry benchmarks, reaching 5.33%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Agilent Technologies's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.68%, the company showcases efficient use of assets and strong financial health.
Debt Management: Agilent Technologies's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.56.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 5 Analysts Discuss Agilent Technologies Stock

Baird analyst Catherine Schulte maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Outperform and lowers the price target from $159 to $140.

Baird Maintains Outperform on Agilent Technologies, Lowers Price Target to $140

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said no to O&#8217;Reilly Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>). 
&#8220;You want to buy the one that's not going to stock split, which is AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>),&#8221;<a href="https://www.benzinga.com/quote/ORLY/earnings"> he added.</a>
Adding support to his view, O&#8217;Reilly Automotive posted first-quarter earnings of $9.35 per share on April 23, missing market estimates of $9.94 per share. The company's quarterly sales came in at $4.14 billion versus expectations of $4.17 billion.
AutoZone has outperformed the market over the past 15 years by 10.81% on an annualized basis producing an average annual return of 22.06%. Currently, the company has a market capitalization of $62.8 billion.
See Also: <a href="https://www.benzinga.com/insights/news/25/05/45322871/heres-how-much-100-invested-in-autozone-15-years-ago-would-be-worth-today">Here&#8217;s How Much $100 Invested In AutoZone 15 Years Ago Would Be Worth Today</a>
Cramer said the last couple quarters have been weak for ASML Holding N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>). He recommended buying Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) over ASML.
Supporting his view, ASML Holding reported a first-quarter sales miss on April 16. Sequentially, revenue declined by 16.75% from €9.3 billion in the fourth quarter.
Cramer said no to Onto Innovation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>), adding that he likes Agilent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>).
Onto Innovation issued second-quarter guidance below estimates on May 8. The company sees second-quarter adjusted EPS of $1.21-$1.35, versus market estimates of $1.50. The company expects sales of $240.00 million —$260.00 million, versus projections of $269.10 million.
The Mad Money host said no to Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>). &#8220;Engineering and construction, we're going to buy letter J, we'll buy Jacobs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>),&#8221; he added.
UBS analyst Steven Fisher maintained Fluor with a buy rating on May 7 and lowered the price target from $49 to $48.
Price Action:
<ul class="wp-block-list">
<li>ASML shares fell 1.4% to settle at $758.36 on Thursday.</li>
<li>O'Reilly Automotive shares rose 3.4% to close at $1,370.13 during the session.</li>
<li>Onto Innovation shares fell 5.8% to settle at $98.04.</li>
<li>Fluor shares fell 0.5% to close at $38.53 on Thursday.</li>
</ul>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Image: Shutterstock

Media

ASML

LRCX

ONTO

ORLY

Jim Cramer Prefers AutoZone Over Rival: 'Buy The One That's Not Going To Stock Split'

Agilent Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) short percent of float has risen 17.01% since its last report. The company recently reported that it has 4.32 million shares sold short, which is 1.72% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.46 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Agilent Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747152025_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Agilent Technologies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Agilent Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Agilent Technologies's peer group average for short interest as a percentage of float is 7.32%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About Agilent Technologies?

Press Releases

Agilent to Participate in Jefferies Global Healthcare Conference

Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series

Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors

Agilent Announces Cash Dividend of 24.8 Cents per Share

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance

Agilent Names August Specht as Chief Technology Officer

Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results

Smackover Lithium's South West Arkansas Project Receives Royalty Rate Approval From the Arkansas Oil and Gas Commission

Agilent to Showcase New Products and Innovations at HPLC 2025

TSXV:SLI

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Agilent Technologies

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL